Laddar...
Protease‐activated receptor 4: from structure to function and back again
Protease‐activated receptors are a family of four GPCRs (PAR1–PAR4) with a number of unique attributes. Nearly two and a half decades after the discovery of the first PAR, an antagonist targeting this receptor has been approved for human use. The first‐in‐class PAR1 antagonist, vorapaxar, was approv...
Sparad:
| I publikationen: | Br J Pharmacol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341247/ https://ncbi.nlm.nih.gov/pubmed/26844674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13455 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|